Showing results (31-40 of 84) with videos related to
Sort By:
Pageof 9
Anti-Cancer Agents in Medicinal Chemistry|January 1, 2013
Multidisciplinary approach to rectal cancer: are we ready for selective treatment strategies?Antonio Avallone, Luigi Aloj, Paolo Delrio, et al.EJNMMI Research|December 17, 2015
Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogueJoachim Pfister, Dominik Summer, Christine Rangger, et al.Chemmedchem|January 3, 2008
Peptide-containing aggregates as selective nanocarriers for therapeuticsAntonella Accardo, Diego Tesauro, Luigi Aloj, et al.Chemmedchem|August 18, 2006
Conformationally constrained CCK8 analogues obtained from a rationally designed peptide library as ligands for cholecystokinin type B receptorStefania De Luca, Michele Saviano, Raffaella Della Moglie, et al.Human Gene Therapy|September 10, 2010
Noninvasive repetitive imaging of somatostatin receptor 2 gene transfer with positron emission tomographyGabriella Cotugno, Michela Aurilio, Patrizia Annunziata, et al.EJNMMI Research|February 22, 2016
Pre-clinical evaluation of eight DOTA coupled gastrin-releasing peptide receptor (GRP-R) ligands for in vivo targeting of receptor-expressing tumorsAntonella Accardo, Filippo Galli, Rosalba Mansi, et al.Biopolymers|July 11, 2008
In vivo and in vitro characterization of CCK8 bearing a histidine-based chelator labeled with 99mTc-tricarbonylLuca D D'Andrea, Irma Testa, Mariarosaria Panico, et al.Molecular Biosystems|June 23, 2010
Peptide modified nanocarriers for selective targeting of bombesin receptorsAntonella Accardo, Rosalba Mansi, Anna Morisco, et al.Frontiers in Immunology|August 15, 2020
Intravital Imaging of Adoptive T-Cell Morphology, Mobility and Trafficking Following Immune Checkpoint Inhibition in a Mouse Melanoma ModelDoreen Lau, Fabien Garçon, Anita Chandra, et al.International Journal of Nanomedicine|May 24, 2012
Peptide-modified liposomes for selective targeting of bombesin receptors overexpressed by cancer cells: a potential theranostic agentAntonella Accardo, Giuseppina Salsano, Anna Morisco, et al.Pageof 9